Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia

被引：178

作者：

Aydemir, H. ^{[1
]}

Akduman, D. ^{[1
]}

Piskin, N. ^{[1
]}

Comert, F. ^{[2
]}

Horuz, E. ^{[1
]}

Terzi, A. ^{[2
]}

Kokturk, F. ^{[3
]}

Ornek, T. ^{[4
]}

Celebi, G. ^{[1
]}

机构：

[1] Bulent Ecevit Univ, Fac Med, Dept Infect Dis & Clin Microbiol, TR-67600 Zonguldak, Turkey

[2] Bulent Ecevit Univ, Fac Med, Dept Microbiol, TR-67600 Zonguldak, Turkey

[3] Bulent Ecevit Univ, Fac Med, Dept Biostat, TR-67600 Zonguldak, Turkey

[4] Bulent Ecevit Univ, Fac Med, Dept Pulm Dis, TR-67600 Zonguldak, Turkey

来源：

EPIDEMIOLOGY AND INFECTION | 2013年 / 141卷 / 06期

关键词：

Acinetobacter baumannii; adverse drug reaction; colistin; ventilator-associated pneumonia; CRITICALLY-ILL PATIENTS; IN-VITRO ACTIVITIES; PSEUDOMONAS-AERUGINOSA; NOSOCOMIAL INFECTIONS; INTRAVENOUS COLISTIN; INHALED COLISTIN; RENAL-FAILURE; POLYMYXIN-B; PHARMACOKINETICS; THERAPY;

D O I：

10.1017/S095026881200194X

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

The aim of this study was to compare the responses of colistin treatment alone vs. a combination of colistin and rifampicin in the treatment of ventilator-associated pneumonia (VAP) caused by a carbapenem-resistant A. baumannii strain. Forty-three patients were randomly assigned to one of two treatment groups. Although clinical (P=0.654), laboratory (P=0.645), radiological (P=0.290) and microbiological (P=0.597) response rates were better in the combination group, these differences were not significant. However, time to microbiological clearance (3.1+/-0.5 days, P=0.029) was significantly shorter in the combination group. The VAP-related mortality rates were 63.6% (14/22) and 38.1% (8/21) for the colistin and the combination groups (P=0.171), respectively. Our results suggest that the combination of colistin with rifampicin may improve clinical and microbiological outcomes of VAP patients infected with A. baumannii.

引用

页码：1214 / 1222

页数：9

共 32 条

[31] The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure [J].

Vincent, JL ;

Moreno, R ;

Takala, J ;

Willatts, S ;

DeMendonca, A ;

Bruining, H ;

Reinhart, CK ;

Suter, PM ;

Thijs, LG .

INTENSIVE CARE MEDICINE, 1996, 22 (07) :707-710

[32] Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review [J].

Zavascki, Alexandre Prehn ;

Goldani, Luciano Zubaran ;

Li, Jian ;

Nation, Roger L. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) :1206-1215

← 1 2 3 4 →